Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814105) titled '[11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study' on Sept. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Chinese University of Hong Kong
Condition:
Primary Aldosteronism
Intervention:
Procedure: [11C] Metomidate PETCT
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2026
Target Sample Size: 32
Countries of Recruitment:
Hong Kong
To know more, visit https://clinicaltrials.gov/study/NCT07...